Case Report of Anti-Thrombogenicity

Case Report of Anti-Thrombogenicity

Abstract Background: The Toray Filtryzer™-NF is a new polymethyl methacrylate filter with improved hemocompatibility and reduced impact on platelet counts. Objectives: This suggests that, if necessary, a reduction in anticoagulation may be possible when dialysis is performed with the Toray Filtryzer...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Blood purification 2023-06, Vol.52 (Suppl 1), p.95-97
Hauptverfasser: Boedecker-Lips, Simone C., Batzke, Katharina, Klimpke, Pascal, Holtz, Stefan, Kraus, Daniel, Weinmann-Menke, Julia
Format: Artikel
Sprache:eng
Schlagworte:
Short Communication
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 97
container_issue Suppl 1
container_start_page 95
container_title Blood purification
container_volume 52
creator Boedecker-Lips, Simone C.
Batzke, Katharina
Klimpke, Pascal
Holtz, Stefan
Kraus, Daniel
Weinmann-Menke, Julia
description Abstract Background: The Toray Filtryzer™-NF is a new polymethyl methacrylate filter with improved hemocompatibility and reduced impact on platelet counts. Objectives: This suggests that, if necessary, a reduction in anticoagulation may be possible when dialysis is performed with the Toray Filtryzer™-NF. Methods: In the following, we dialyzed 5 hemodialysis patients who had a contraindication to full anticoagulation postoperatively or after renal biopsy with the Filtryzer™-NF. Results: A significant reduction in heparin administration was achieved, and in 1 patient, heparin substitution was completely omitted. Despite the significantly reduced heparin doses, no thrombosis of the system occurred during the hemodialysis. Conclusion: In conclusion, hemodialysis using the Toray Filtryzer™-NF is an effective alternative for patients at significantly increased risk of bleeding.
doi_str_mv 10.1159/000530850
format Article
fullrecord <record><control><sourceid>proquest_karge</sourceid><recordid>TN_cdi_karger_primary_530850</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2827664714</sourcerecordid><originalsourceid>FETCH-LOGICAL-c385t-263a3e7aa859758b729cb9843bff5af330d132aff2d5b7aabcd78392147efd8a3</originalsourceid><addsrcrecordid>eNpt0M9LwzAUB_AgipvTg3eRwS56qCZ5TZOeZA5_wUCR7RzSNtmqbVOTTth_b6WzKHjK4X3e94UvQqcEXxHC4muMMQMsGN5DQxJSEsQc2D4aYsogYDgSA3Tk_RvGJIxYfIgGwAEIMDJEk5nyevyqa-uasTXjadXkwWLtbJnYla7yNG-2x-jAqMLrk907Qsv7u8XsMZg_PzzNpvMgBcGagEagQHOlBIs5EwmncZrEIoTEGKYMAM4IUGUMzVjSsiTNuICYkpBrkwkFI3TT5dabpNRZqqvGqULWLi-V20qrcvl3UuVrubKfkhBKIxKLNuFil-Dsx0b7Rpa5T3VRqErbjZdUUB5FISdhSy87mjrrvdOmv0Ow_G5V9q229vz3x3r5U2MLzjrwrtxKux70-5N_x7cvy07IOjPwBZuBhlY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2827664714</pqid></control><display><type>article</type><title>Case Report of Anti-Thrombogenicity</title><source>Karger Journals</source><creator>Boedecker-Lips, Simone C. ; Batzke, Katharina ; Klimpke, Pascal ; Holtz, Stefan ; Kraus, Daniel ; Weinmann-Menke, Julia</creator><creatorcontrib>Boedecker-Lips, Simone C. ; Batzke, Katharina ; Klimpke, Pascal ; Holtz, Stefan ; Kraus, Daniel ; Weinmann-Menke, Julia</creatorcontrib><description>Abstract Background: The Toray Filtryzer™-NF is a new polymethyl methacrylate filter with improved hemocompatibility and reduced impact on platelet counts. Objectives: This suggests that, if necessary, a reduction in anticoagulation may be possible when dialysis is performed with the Toray Filtryzer™-NF. Methods: In the following, we dialyzed 5 hemodialysis patients who had a contraindication to full anticoagulation postoperatively or after renal biopsy with the Filtryzer™-NF. Results: A significant reduction in heparin administration was achieved, and in 1 patient, heparin substitution was completely omitted. Despite the significantly reduced heparin doses, no thrombosis of the system occurred during the hemodialysis. Conclusion: In conclusion, hemodialysis using the Toray Filtryzer™-NF is an effective alternative for patients at significantly increased risk of bleeding.</description><identifier>ISSN: 0253-5068</identifier><identifier>ISSN: 1421-9735</identifier><identifier>EISSN: 1421-9735</identifier><identifier>DOI: 10.1159/000530850</identifier><identifier>PMID: 37331351</identifier><language>eng</language><publisher>Basel, Switzerland: S. Karger AG</publisher><subject>Short Communication</subject><ispartof>Blood purification, 2023-06, Vol.52 (Suppl 1), p.95-97</ispartof><rights>2023 The Author(s). Published by S. Karger AG, Basel</rights><rights>2023 The Author(s). Published by S. Karger AG, Basel.</rights><rights>2023 The Author(s). Published by S. Karger AG, Basel 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c385t-263a3e7aa859758b729cb9843bff5af330d132aff2d5b7aabcd78392147efd8a3</cites><orcidid>0000-0002-6351-3706</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,2423,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37331351$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Boedecker-Lips, Simone C.</creatorcontrib><creatorcontrib>Batzke, Katharina</creatorcontrib><creatorcontrib>Klimpke, Pascal</creatorcontrib><creatorcontrib>Holtz, Stefan</creatorcontrib><creatorcontrib>Kraus, Daniel</creatorcontrib><creatorcontrib>Weinmann-Menke, Julia</creatorcontrib><title>Case Report of Anti-Thrombogenicity</title><title>Blood purification</title><addtitle>Blood Purif</addtitle><description>Abstract Background: The Toray Filtryzer™-NF is a new polymethyl methacrylate filter with improved hemocompatibility and reduced impact on platelet counts. Objectives: This suggests that, if necessary, a reduction in anticoagulation may be possible when dialysis is performed with the Toray Filtryzer™-NF. Methods: In the following, we dialyzed 5 hemodialysis patients who had a contraindication to full anticoagulation postoperatively or after renal biopsy with the Filtryzer™-NF. Results: A significant reduction in heparin administration was achieved, and in 1 patient, heparin substitution was completely omitted. Despite the significantly reduced heparin doses, no thrombosis of the system occurred during the hemodialysis. Conclusion: In conclusion, hemodialysis using the Toray Filtryzer™-NF is an effective alternative for patients at significantly increased risk of bleeding.</description><subject>Short Communication</subject><issn>0253-5068</issn><issn>1421-9735</issn><issn>1421-9735</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>M--</sourceid><recordid>eNpt0M9LwzAUB_AgipvTg3eRwS56qCZ5TZOeZA5_wUCR7RzSNtmqbVOTTth_b6WzKHjK4X3e94UvQqcEXxHC4muMMQMsGN5DQxJSEsQc2D4aYsogYDgSA3Tk_RvGJIxYfIgGwAEIMDJEk5nyevyqa-uasTXjadXkwWLtbJnYla7yNG-2x-jAqMLrk907Qsv7u8XsMZg_PzzNpvMgBcGagEagQHOlBIs5EwmncZrEIoTEGKYMAM4IUGUMzVjSsiTNuICYkpBrkwkFI3TT5dabpNRZqqvGqULWLi-V20qrcvl3UuVrubKfkhBKIxKLNuFil-Dsx0b7Rpa5T3VRqErbjZdUUB5FISdhSy87mjrrvdOmv0Ow_G5V9q229vz3x3r5U2MLzjrwrtxKux70-5N_x7cvy07IOjPwBZuBhlY</recordid><startdate>20230616</startdate><enddate>20230616</enddate><creator>Boedecker-Lips, Simone C.</creator><creator>Batzke, Katharina</creator><creator>Klimpke, Pascal</creator><creator>Holtz, Stefan</creator><creator>Kraus, Daniel</creator><creator>Weinmann-Menke, Julia</creator><general>S. Karger AG</general><scope>M--</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-6351-3706</orcidid></search><sort><creationdate>20230616</creationdate><title>Case Report of Anti-Thrombogenicity</title><author>Boedecker-Lips, Simone C. ; Batzke, Katharina ; Klimpke, Pascal ; Holtz, Stefan ; Kraus, Daniel ; Weinmann-Menke, Julia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c385t-263a3e7aa859758b729cb9843bff5af330d132aff2d5b7aabcd78392147efd8a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Short Communication</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Boedecker-Lips, Simone C.</creatorcontrib><creatorcontrib>Batzke, Katharina</creatorcontrib><creatorcontrib>Klimpke, Pascal</creatorcontrib><creatorcontrib>Holtz, Stefan</creatorcontrib><creatorcontrib>Kraus, Daniel</creatorcontrib><creatorcontrib>Weinmann-Menke, Julia</creatorcontrib><collection>Karger Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Blood purification</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Boedecker-Lips, Simone C.</au><au>Batzke, Katharina</au><au>Klimpke, Pascal</au><au>Holtz, Stefan</au><au>Kraus, Daniel</au><au>Weinmann-Menke, Julia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Case Report of Anti-Thrombogenicity</atitle><jtitle>Blood purification</jtitle><addtitle>Blood Purif</addtitle><date>2023-06-16</date><risdate>2023</risdate><volume>52</volume><issue>Suppl 1</issue><spage>95</spage><epage>97</epage><pages>95-97</pages><issn>0253-5068</issn><issn>1421-9735</issn><eissn>1421-9735</eissn><abstract>Abstract Background: The Toray Filtryzer™-NF is a new polymethyl methacrylate filter with improved hemocompatibility and reduced impact on platelet counts. Objectives: This suggests that, if necessary, a reduction in anticoagulation may be possible when dialysis is performed with the Toray Filtryzer™-NF. Methods: In the following, we dialyzed 5 hemodialysis patients who had a contraindication to full anticoagulation postoperatively or after renal biopsy with the Filtryzer™-NF. Results: A significant reduction in heparin administration was achieved, and in 1 patient, heparin substitution was completely omitted. Despite the significantly reduced heparin doses, no thrombosis of the system occurred during the hemodialysis. Conclusion: In conclusion, hemodialysis using the Toray Filtryzer™-NF is an effective alternative for patients at significantly increased risk of bleeding.</abstract><cop>Basel, Switzerland</cop><pub>S. Karger AG</pub><pmid>37331351</pmid><doi>10.1159/000530850</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0002-6351-3706</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0253-5068
ispartof Blood purification, 2023-06, Vol.52 (Suppl 1), p.95-97
issn 0253-5068
1421-9735
1421-9735
language eng
recordid cdi_karger_primary_530850
source Karger Journals
subjects Short Communication
title Case Report of Anti-Thrombogenicity
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T13%3A54%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_karge&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Case%20Report%20of%20Anti-Thrombogenicity&rft.jtitle=Blood%20purification&rft.au=Boedecker-Lips,%20Simone%20C.&rft.date=2023-06-16&rft.volume=52&rft.issue=Suppl%201&rft.spage=95&rft.epage=97&rft.pages=95-97&rft.issn=0253-5068&rft.eissn=1421-9735&rft_id=info:doi/10.1159/000530850&rft_dat=%3Cproquest_karge%3E2827664714%3C/proquest_karge%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2827664714&rft_id=info:pmid/37331351&rfr_iscdi=true